 產品搜索 |
| 產品類別 |
| 推薦產品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3-? |
| 1,3-二苯基異苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧? |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮雜吲哚 |
| 4-氮雜吲哚 |
| 5-氮雜吲哚 |
| 6-氮雜吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖鹽酸鹽 |
| N-乙酰基-D-氨基半乳糖? |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-賴氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯? |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基異 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基? |
| 2-氯-1-甲基吡啶碘鹽 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三異丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 產品展示 |
| 產品編號 |
產品名稱 |
CAS No. |
含量 |
| RovathinS18518 | 3-Pyridinecarboxylic
acid, 2-amino-6-[2-(cyclopropylmethoxy)-6-[(4-methoxyphenyl)methoxy]phenyl]-4-[1-[(1,1-dimethylethoxy)carbonyl]-3-
piperidinyl]-, 1,1-dimethylethyl ester | 405239-75-0 | 95% |
| RovathinS18519 | Hexadecanamide, N-[(1R,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-(1-pyrrolidinylmethyl)
ethyl]- | 245329-77-5 | 95% |
| RovathinS18520 | Benzo[b]thiophene-2-carboximidamide, 6-(benzoyloxy)- | 217099-39-3 | 95% |
| RovathinS18521 | Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-
yl)- | 211096-49-0 | 95% |
| | | 95% | C21H28FNO2 |
| RovathinS18523 | 3-
Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-α-methyl-2,6-bis(1-methylethyl)-5-pentyl-, (αR,4S)-rel- | 202917-16-6 | 95% |
| RovathinS18524 | D-erythro-
Pentofuranose, 2-deoxy-, 1-acetate 3,5-dibenzoate | 51255-12-0 | 95% |
| RovathinS18525 | 1H-Pyrrolo[2,3-b]pyridine-3-carboxaldehyde, 4-methyl- | 4894-34-2 | 95% |
| RovathinS18526 | 1H-Indole-1,7-
dicarboxylic acid, 2-borono-, 1-(1,1-dimethylethyl) 7-methyl ester | 953411-05-7 | 95% |
| RovathinS18527 | 5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-
pyrazole-3-carboxylic acid | 162758-35-2 | 95% |
| RovathinS18528 | 1H-Indole-1-carboxylic acid, 2-borono-5-(methylthio)-, 1-(1,1-dimethylethyl) ester | 945493-45-8 | 95% |
| RovathinS18529 | 1H-
Indole-1-carboxylic acid, 2-borono-5-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-[[2-[[(1,1-dimethylethyl)dimethylsilyl]
oxy]ethyl]ethylamino]propoxy]-, 1-(1,1-dimethylethyl) ester | 913388-77-9 | 95% |
| RovathinS18530 | 1H-Indole-1-carboxylic acid, 2-borono-5-[[(1,1-
dimethylethoxy)carbonyl]amino]-, 1-(1,1-dimethylethyl) ester | 913388-66-6 | 95% |
| RovathinS18531 | 1-(4-Chlorophenyl)-1-propanone | 6285-05-8 | 95% |
| RovathinS18532 | 1H-Indole-1-carboxylic acid, 3-
(1-cyano-1-methylethyl)-5-methoxy-, 1,1-dimethylethyl ester | 907602-77-1 | 95% |
| RovathinS18533 | Boronic acid, B-[1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo
[2,3-b]pyridin-3-yl]- | 882562-39-2 | 95% |
| RovathinS18534 | 1H-Pyrrolo[2,3-b]pyridine, 3-(chloromethyl)-1-[tris(1-methylethyl)silyl]- | 873786-04-0 | 95% |
| RovathinS18535 | 1H-Pyrrolo[2,3-b]pyridine,
4-chloro-1-[(4-methylphenyl)sulfonyl]-3-(trifluoromethyl)- | 869335-74-0 | 95% |
| RovathinS18536 | Methanone, [4-(2-chlorophenyl)-1-piperazinyl](3,5-
dimethyl-4-isoxazolyl)- | 849478-04-2 | 95% |
| RovathinS18537 | 4-Bromo-2-chlorophenol | 3964-56-5 | 95% |
| RovathinS18538 | 1H-Indole-1-carboxylic acid, 5-acetyl-2-borono-, 1-(1,1-
dimethylethyl) ester | 848357-29-9 | 95% |
| RovathinS18539 | 1-Piperidinecarboxylic acid, 2-(aminomethyl)-, 1,1-dimethylethyl ester, (2R)- | 683233-14-9 | 95% |
| RovathinS18540 | 1H-Pyrrolo[2,3-b]
pyridine, 4-bromo-1-[tris(1-methylethyl)silyl]- | 640735-24-6 | 95% |
| RovathinS18541 | 1H-Pyrrolo[2,3-b]pyridine, 5-(4-ethylphenyl)- | 611205-41-5 | 95% |
| RovathinS18542 | Quinazoline, 6-bromo-2-chloro- | 882672-05-1 | 95% |
| RovathinS18543 | Quinazoline, 6-bromo-2-iodo- | 882670-93-1 | 95% |
| RovathinS18544 | 1H-Indazole-3-carboxylic acid, 4-methoxy- | 865887-
02-1 | 95% |
| RovathinS18545 | 3-
Quinolinecarboxylic acid, 7-bromo-4-hydroxy- | 860205-92-1 | 95% |
| RovathinS18546 | 1,2-Benzisothiazole-3-carboxylic acid, 6-bromo-, ethyl ester | 858671-
74-6 | 95% |
| RovathinS18547 | 1H-Indazole-3
-carboxylic acid, 6-nitro- | 857801-97-9 | 95% |
|
|
|
|
